Lauxera Capital Partners signs a partnership with Institut Imagine to fund groundbreaking research into rare diseases Lauxera 10 October, 2023
Creation of Ospi, the result of the merger between Groupe PSIH and Collective Thinking Lauxera 26 September, 2023
Lauxera Capital Partners invests €17 million in Swedish regenerative medicine leader BioLamina AB Lauxera 12 September, 2023
Caresyntax, Relyens and Intel are collaborating to launch the Connected Surgery program Lauxera 3 Mai, 2023
Lauxera Capital Partners invests €10m in German Medtech software company Matrix Requirements Lauxera 16 June, 2022